Please assess the completion status of the following clinical trial:

Trial Title: Thyroxine Replacement in Organ Donors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Brain death criteria established~2. Consent for organ donation received~Exclusion Criteria:~1. immediate (\< 4 Hrs) organ retrieval anticipated

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- po thyroxine (Type: ACTIVE_COMPARATOR): placebo is iv
- iv thyroxine (Type: ACTIVE_COMPARATOR): placebo is po

Based on this trial design, predict the completion outcome and termination type (if applicable).